Claude noticed something in genetic data that researchers had not described: a repeating pattern beside an enzyme gene. Anthropic says the observation led to a previously uncharacterized biological system, which its scientists are now investigating.
The September 23 announcement calls it array-associated reverse transcriptase, or ART. Its repeating DNA resembles a feature of CRISPR. Whether ART can become a useful biotechnology tool is still an open question.
What Claude found
Researchers gave Claude a broad assignment to find unusual systems involving reverse transcriptases, enzymes that copy RNA into DNA. According to the technical report, the search ran for about 21 hours across roughly 950 agent sessions, ending with 19 reports for human review.
Agents could follow unexpected observations, question their own explanations and open new investigations. One pursued an odd enzyme in viruses that infect bacteria. Reading nearby DNA directly, it spotted repeated sequences and checked whether the pattern matched anything already described.
The enzyme itself had appeared in earlier research. Anthropic says the discovery was recognizing the larger system around it: the enzyme, an accompanying protein and an array of repeated DNA.
Why the CRISPR comparison needs context
CRISPR’s repeat arrays help make it programmable. ART has a similar-looking arrangement, and the researchers observed that its array produces distinct short RNAs. That makes the system interesting to investigate; it does not establish that it edits genes.
The preprint states that the team has not yet shown the reverse transcriptase is active or that these RNAs are what it acts on. The system’s biological purpose and the role of its partner protein remain unknown.
The 21-hour figure describes the computational search, not a complete laboratory discovery cycle. Anthropic says human scientists perform all of its lab work. Further experiments are underway.
The result shows an AI system identifying a research lead in raw data and building a case for scientists to examine. Establishing what that lead can actually do is the next part of the story.